Si-Bone (SIBN) Preferred Stock Liabilities (2017 - 2018)
Si-Bone's (SIBN) quarterly Preferred Stock Liabilities came in at $118.5 million in Q3 2018, up 27991.94% quarter-over-quarter from $422000.0 in Q4 2017.
Si-Bone (SIBN) Preferred Stock Liabilities (2017 - 2018) Analysis & Trends
Si-Bone's Preferred Stock Liabilities history runs 2 years deep, the most recent figure standing at $118.5 million for Q3 2018.
- On a quarterly basis, Preferred Stock Liabilities changed N/A year-over-year to $118.5 million in Q3 2018; TTM through Sep 2018 was $118.5 million, a N/A change from a year earlier, with the FY2017 full-year figure at $422000.0, changed N/A from the prior year.
- Preferred Stock Liabilities rose to $118.5 million in Q3 2018 per SIBN's latest filing, from $422000.0 in the prior quarter.
- Across five years, Preferred Stock Liabilities topped out at $118.5 million in Q3 2018 and bottomed at $422000.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Si-Bone | 724.02 Mn | 579.33 Mn | 41.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 118.55 Mn |
| Dec 31, 2017 | 422,000.00 |